Manorama Industries completes postal ballot dispatch for independent director appointment
- Manorama Industries completed dispatch of postal ballot notice on September 18, 2026
- Shareholders can vote remotely from September 19 to October 18, 2026
- Dr. Rohini Tiwari proposed for five-year term as independent director
- No physical ballot forms issued; e-voting is mandatory per MCA guidelines
*this image is generated using AI for illustrative purposes only.
Manorama Industries has completed the dispatch of its postal ballot notice seeking shareholder approval to appoint Dr. Rohini Tiwari as a non-executive independent director. The company confirmed the completion of dispatch on September 18, 2026, via advertisements in Business Standard and Loksatta.
The Board of Directors initially approved the appointment on September 4, 2026, following recommendations from the Nomination and Remuneration Committee. Dr. Tiwari was appointed as an additional director on that date pursuant to Section 161 of the Companies Act, 2013. The proposed term spans five consecutive years, commencing on September 4, 2026, and ending on September 3, 2031.
Voting Process
Shareholders holding equity shares as of the cut-off date of September 11, 2026, are eligible to vote via remote e-voting only. No physical ballot forms are being dispatched in compliance with Ministry of Corporate Affairs circulars. The voting window opens at 9:00 am on Saturday, September 19, 2026, and closes at 5:00 pm on Sunday, October 18, 2026.
The company has engaged MUFG Intime India Private Limited to facilitate the electronic voting process. Members holding shares in physical form without registered email IDs must register their details with the Registrar & Share Transfer Agent or the Company to enable voting. Those holding shares in dematerialized mode should update their email IDs with their Depository Participants.
M/s. Mehta & Mehta has been appointed as the scrutinizer to oversee the postal ballot process. Ms. Alifya Sapatwala will represent the firm, with Ms. Namrata Tatiya serving as alternate representative. Once cast, votes cannot be changed or recast. If approved, the resolution will be deemed passed on the last day of e-voting.
Director Profile
Dr. Rohini Tiwari brings multidisciplinary experience in food technology, nutrition, and quality assurance. She holds a Ph.D. in Food Science and Nutrition and has served as Chief Clinical Nutritionist at Ganga Hospital, Coimbatore. Her industry background includes quality assurance roles at Hindustan Coca-Cola Beverages Pvt. Ltd. and nutraceutical R&D consultancy with Dr. Reddy's Laboratories.
| Detail | Information |
|---|---|
| DIN | 11924749 |
| Term Duration | Five years (September 4, 2026 – September 3, 2031) |
| Remuneration | Sitting fees as per Companies Act, 2013 |
| Shareholding | Nil |
| Current Directorships | Nil |
The appointment is subject to member approval via special resolution. The results will be declared within two working days from the closure of e-voting, expected by October 20, 2026.
Historical Stock Returns for Manorama Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.25% | +8.67% | -4.20% | +56.03% | +43.08% | +895.95% |
How might Dr. Tiwari's expertise in food technology and quality assurance influence Manorama Industries' strategic direction in its core manufacturing segments?
What potential impact could the addition of an independent director with a clinical nutrition background have on the company's ESG reporting and sustainability initiatives?
Will the approval of this appointment signal broader changes to the Board's composition or governance policies in the upcoming fiscal year?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
